Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mark Hamblin"'
Publikováno v:
European Respiratory Review, Vol 31, Iss 163 (2022)
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease (ILD) that occurs when susceptible individuals develop an exaggerated immune response to an inhaled antigen. In this review, we discuss the latest guidelines f
Externí odkaz:
https://doaj.org/article/950b0a583bba4dddaf4c9f1bdb5ba106
Autor:
Ayodeji Adegunsoye, Justin M. Oldham, Evans R. Fernández Pérez, Mark Hamblin, Nina Patel, Mitchell Tener, Deepa Bhanot, Lacey Robinson, Sam Bullick, Lena Chen, Scully Hsu, Matthew Churpek, Donald Hedeker, Steven Montner, Jonathan H. Chung, Aliya N. Husain, Imre Noth, Mary E. Strek, Rekha Vij
Publikováno v:
ERJ Open Research, Vol 3, Iss 3 (2017)
In chronic hypersensitivity pneumonitis (CHP), lack of improvement or declining lung function may prompt use of immunosuppressive therapy. We hypothesised that use of azathioprine or mycophenolate mofetil with prednisone reduces adverse events and lu
Externí odkaz:
https://doaj.org/article/25455b445f8549b9b17a7d8e12464f0e
Autor:
Janet Lee, Emily White, Elizabeth Freiheit, Mary Beth Scholand, Mary E. Strek, Anna J. Podolanczuk, Nina M. Patel, Rebecca Bascom, Elizabeth Belloli, Nitin Bhatt, Sangeeta Bhorade, Amy Case, Richard Castriotta, Gerard Criner, Sonye Danoff, Joao De Andrade, Alpa Desai, Marilyn Glassberg, Craig Glazer, Mridu Gulati, Nishant Gupta, Mark Hamblin, Tristan Huie, Robert Kaner, Daniel Kass, Hyun Kim, Maryl Kreider, Lisa Lancaster, Joseph Lasky, Andrew Limper, Sydney Montesi, Joshua Mooney, Lake Morrison, Anoop Nambiar, Steven Nathan, Bhupinder Natt, Tessy Paul, Rafael Perez, Anna Podolanczuk, Ganesh Raghu, Adrian Shifren, Mary Strek, Nevins Todd, Rajat Walia, Stephen Weight, Timothy Whelan, Paul Wolters
Publikováno v:
Chest. 162:603-613
Autor:
Frank Yocca, Carlos M. Villalon, Andrew Sleight, Trevor Sharp, Pramod R. Saxena, Bryan Roth, John A. Peters, Stephen J. Peroutka, John Neumaier, Ewan Mylecharane, Derek N. Middlemiss, Graeme R. Martin, Luc Maroteaux, Klaus Peter Latté, Patrick P. A. Humphrey, Daniel Hoyer, Rebecca Hills, Katharine Herrick-Davis, Julie Hensler, René Hen, Paul R. Hartig, Michel Hamon, Mark Hamblin, Manfred Göthert, Richard M. Eglen, Aline Dumuis, Marlene L. Cohen, Amy Butler, Theresa Branchek, Joel Bockaert, Gordon Baxter, Nicholas M. Barnes, Rodrigo Andrade
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2023
5-HT receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on 5-HT receptors [198] and subsequently revised [180]) are, with the exception of the ionotropic 5-HT3 class, GPCRs where the endogenous agonist is 5-hydroxytryptamine. The diversi
Autor:
Joshua J. Mooney, Daniel A. Culver, Sachin Chaudhary, Murali Ramaswamy, Gregory P. Cosgrove, Alpa G. Desai, Sonye K. Danoff, Amy Case, Stephen Weight, Rodeo Abrencillo, Joseph D. Zibrak, Srihari Veeraraghavan, Barry S. Shea, Nitin Y. Bhatt, Maryl Kreider, Doug Moore, Mary Beth Scholand, Shelley L. Schmidt, Thomas H. Schaumberg, Christopher S. King, Borna Mehrad, Justin M. Oldham, Bridget A. Graney, Adrian Shifren, Christophe He, Nathan Sandbo, Nishant Gupta, Michael Marll, Daniel F. Dilling, Tracy Luckhardt, Mridu Gulati, Tristan J. Huie, Craig S. Glazer, Nevins W. Todd, Peter Lacamera, Hyun Koo Kim, Mohamed Saad, Pauline Bianchi, James R. McCormick, Mark Hamblin, Yolanda N. Mageto, Robert Matthew Kottman, Teng Moua, Anna J. Podolanczuk, Scott Matson, Divya Patel, David Roe, Mary E. Strek, Lisa Lancaster, Krishna Thavarajah, Paul J. Wolters, Joyce S. Lee, Sydney B. Montesi, Rafael L. Perez, Rebecca Bascom, Nabeel Hamzeh, Tessy K. Paul, Anoop M. Nambiar, Prema Menon
Publikováno v:
Chest. 159:1517-1530
Background Management of patients with interstitial lung disease (ILD) requires subspecialized, comprehensive, multidisciplinary care. The Pulmonary Fibrosis Foundation established the Care Center Network (CCN) in 2013 with identified criteria to bec
Publikováno v:
European respiratory review : an official journal of the European Respiratory Society. 31(163)
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease (ILD) that occurs when susceptible individuals develop an exaggerated immune response to an inhaled antigen. In this review, we discuss the latest guidelines f
Publikováno v:
A37. ILD THERAPY I.
Publikováno v:
Chest. 160:A1276
Publikováno v:
Critical Care Medicine. 40:1-328
Autor:
Usman Nazir, Mark Hamblin
Publikováno v:
Chest. 146:381A